CureVac NV
NASDAQ:CVAC

Watchlist Manager
CureVac NV Logo
CureVac NV
NASDAQ:CVAC
Watchlist
Price: 2.99 USD 1.01%
Market Cap: 670.7m USD
Have any thoughts about
CureVac NV?
Write Note

CureVac NV
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CureVac NV
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
CureVac NV
NASDAQ:CVAC
Cash Interest Paid
€2.4m
CAGR 3-Years
-35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Cash Interest Paid
€5.4m
CAGR 3-Years
11%
CAGR 5-Years
22%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Cash Interest Paid
€1.2m
CAGR 3-Years
-10%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Cash Interest Paid
€290k
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Cash Interest Paid
€24.2m
CAGR 3-Years
30%
CAGR 5-Years
15%
CAGR 10-Years
-2%
Formycon AG
XETRA:FYB
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CureVac NV
Glance View

Market Cap
670.8m USD
Industry
Biotechnology

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Tuebingen, Baden-Wuerttemberg and currently employs 500 full-time employees. The company went IPO on 2020-08-14. The firm is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The firm's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.

CVAC Intrinsic Value
4.32 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is CureVac NV's Cash Interest Paid?
Cash Interest Paid
2.4m EUR

Based on the financial report for Dec 31, 2023, CureVac NV's Cash Interest Paid amounts to 2.4m EUR.

What is CureVac NV's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
-35%

Over the last year, the Cash Interest Paid growth was -48%. The average annual Cash Interest Paid growth rates for CureVac NV have been -35% over the past three years .

Back to Top